# Pain Control Following Total Hip Arthroplasty

> **NCT05062356** · PHASE1 · COMPLETED · sponsor: **St. Mary's Research Center, Canada** · enrollment: 240 (actual)

## Conditions studied

- Chronic Postoperative Pain

## Interventions

- **DRUG:** Bupivacaine Hydrochloride 0.25% Injection Solution_#2
- **DRUG:** EPINEPHrine 1:200,000 / Prilocaine HCl 4 % 1.8 ML Cartridge
- **DRUG:** Bupivacaine Hydrochloride 0.5% Injection Solution_#2
- **DRUG:** Ketorolac

## Key facts

- **NCT ID:** NCT05062356
- **Lead sponsor:** St. Mary's Research Center, Canada
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-04
- **Primary completion:** 2024-08-15
- **Final completion:** 2024-08-15
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2024-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05062356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05062356, "Pain Control Following Total Hip Arthroplasty". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05062356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*